Abstract
Since a mature mammalian erythrocyte is enucleated and it is void of mitochondria, gene expression does not take place, while glycolysis is the only mechanism to produce ATP. This simplicity makes its metabolism unique from other cells. Due to its simple structure and the traceability of the cell, erythrocyte metabolism and enzymology have been well studied over the last three to four decades. Although vast amounts of erythrocyte component information is available, the quantitative and physiological role of the metabolism is still an open question because the nature of the cellular function is the complex dynamics of components. Mathematical models for biochemical pathways comprising complex networks are of particular interest in order to identify the features of biological systems that cannot be investigated by the analysis of their individual components alone. Because of its simplicity, the robustness of the erythrocyte that enables the cell to circulate in the body for about 120 days and the abundance of knowledge, erythrocytes have been a good subject for numerous modeling and simulation studies. There is a long history of detailed metabolic models of erythrocyte metabolism with differential equations. The first mathematical models of erythrocyte metabolism were developed by Rapoport et al and the model by Heinrich et al, which only included the glycolytic pathway.1–3 Ataullakhanov et al expanded the glycolytic model to represent the pentose phosphate pathway.4 Subsequently, adenine nucleotide metabolism was first considered by Schauer et al.5 The comprehensive biochemical network, which has been widely accepted as the complete network of the metabolic system in erythrocytes, was reconstructed by Joshi and Palsson in 1989–1990, involving membrane transports, the Na+/K+ pump and osmotic pressure.6–9
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rapoport TA, Otto M, Heinrich R. An extended model of the glycolysis in erythrocytes. Acta Biol Med Ger 1997; 36:461–8.
Heinrich R, Rapoport SM, Rapoport TA. Metabolic regulation and mathematical models. Prog Biophys Mol Biol 1977; 32:1–82.
Rapoport TA, Heinrich R, Rapoport SM. The regulatory principles of glycolysis in erythrocytes in vivo and in vitro. A minimal comprehensive model describing steady states, quasi-steady states and time-dependent processes. Biochem J 1976; 154:449–69.
Ataullakhanov FI, Vitvitsky VM, Zhabotinsky AM et al. The regulation of glycolysis in human erythrocytes. The dependence of the glycolytic flux on the ATP concentration. Eur J Biochem 1981; 115:359–65.
Schauer M, Heinrich R, Rapoport SM. [Mathematical modelling of glycolysis and adenine nucleotide metabolism of human erythrocytes. I. Reaction-kinetic statements, analysis of in vivo state and determination of starting conditions for in vitro experiments]. Acta Biol Med Ger 1981; 40:1659–82.
Joshi A, Palsson BO. Metabolic dynamics in the human red cell. Part I—A comprehensive kinetic model. J Theor Biol 1989; 141:515–28.
Joshi A, Palsson BO. Metabolic dynamics in the human red cell. Part II—Interactions with the environment. J Theor Biol 1989; 141:529–45.
Joshi A, Palsson BO. Metabolic dynamics in the human red cell. Part III—Metabolic reaction rates. J Theor Biol 1990; 142:41–68.
Joshi A, Palsson BO. Metabolic dynamics in the human red cell. Part IV—Data prediction and some model computations. J Theor Biol 1990; 142:69–85.
Mulquiney PJ, Bubb WA, Kuchel PW. Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: in vivo kinetic characterization of 2,3-bisphosphoglycerate synthase/phosphatase using 13C and 31P NMR. Biochem J 1999; 342 Pt 3: 567–80.
Mulquiney PJ, Kuchel PW. Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement. Biochem J 1999; 342 Pt 3:581–96.
Nakayama Y, Kinoshita A, Tomita M. Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition. Theor Biol Med Model 2005; 2:18.
Kinoshita A, Nakayama Y, Kitayama T et al. Simulation study of methemoglobin reduction in erythrocytes. Differential contributions of two pathways to tolerance to oxidative stress. Febs J 2007; 274:1449–58.
Kinoshita A, Tsukada K, Soga T et al. Roles of hemoglobin Allostery in hypoxia-induced metabolic alterations in erythrocytes: simulation and its verification by metabolome analysis. J Biol Chem 2007; 282:10731–41.
Ferretti A, Bozzi A, Di Vito M et al. 13C and 31P NMR studies of glucose and 2-deoxyglucose metabolism in normal and enzyme-deficient human erythrocytes. Clin Chim Acta 1992; 208:39–61.
Meister A. Glutathione, metabolism and function via the gamma-glutamyl cycle. Life Sci 1974; 15:177–90.
Srivastava SK, Beutler E. The transport of oxidized glutathione from human erythrocytes. J Biol Chem 1969; 244:9–16.
Kondo T, Beutler E. Developmental changes in glucose transport of guinea pig erythrocytes. J Clin Invest 1980; 65:1–4.
Hebbel RP. Erythrocyte antioxidants and membrane vulnerability. J Lab Clin Med 1986; 107:401–4.
Rice-Evans C, Omorphos SC, Baysal E. Sickle cell membranes and oxidative damage. Biochem J 1986; 237:265–9.
Jaffe ER. Methaemoglobinaemia. Clin Haematol 1981; 10:99–122.
Mansouri A, Lurie AA. Concise review: methemoglobinemia. Am J Hematol 1993; 42:7–12.
Yubisui T, Takeshita M. Purification and properties of soluble NADH-cytochrome b5 reductase of rabbit erythrocytes. J Biochem (Tokyo) 1982; 91:1467–77.
Yubisui T, Murakami K, Shirabe K et al. Structural analysis of NADH-cytochrome b5 reductase in relation to hereditary methemoglobinemia. Prog Clin Biol Res 1989; 319:107–19; discussion 120–1.
Yubisui T, Takeshita M, Yoneyama Y. Reduction of methemoglobin through flavin at the physiological concentration by NADPH-flavin reductase of human erythrocytes. J Biochem (Tokyo) 1980; 87:1715–20.
Hultquist DE, Passon PG. Catalysis of methaemoglobin reduction by erythrocyte cytochrome B5 and cytochrome B5 reductase. Nat New Biol 1971; 229:252–4.
Wang Y, Wu YS, Zheng PZ et al. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia. Blood 2000; 95:3250–5.
Yubisui T, Matsuki T, Takeshita M et al. Characterization of the purified NADPH-flavin reductase of human erythrocytes. J Biochem (Tokyo) 1979; 85:719–28.
Quandt KS, Hultquist DE. Flavin reductase: sequence of cDNA from bovine liver and tissue distribution. Proc Natl Acad Sci U S A 1994; 91:9322–6.
Zhu H, Qiu H, Yoon HW et al. Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells. Proc Natl Acad Sci U S A 1999; 96:14742–7.
Salvador A, Savageau MA. Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes. Proc Natl Acad Sci U S A 2003; 100:14463–8.
Salvador A, Savageau MA. Evolution of enzymes in a series is driven by dissimilar functional demands. Proc Natl Acad Sci U S A 2006; 103:2226–31.
Higasa K, Manabe JI, Yubisui T et al. Molecular basis of hereditary methaemoglobinaemia, types I and II: two novel mutations in the NADH-cytochrome b5 reductase gene. Br J Haematol 1998; 103:922–30.
Kuma F. Properties of methemoglobin reductase and kinetic study of methemoglobin reduction. J Biol Chem 1981; 256:5518–23.
Abe K, Sugita Y. Properties of cytochrome b5 and methemoglobin reduction in human erythrocytes. Eur J Biochem 1979; 101:423–8.
Cunningham O, Gore MG, Mantle TJ. Initial-rate kinetics of the flavin reductase reaction catalysed by human biliverdin-IXbeta reductase (BVR-B). Biochem J 2000; 345 Pt 2:393–9.
Kuma F, Inomata H. Studies on methemoglobin reductase. II. The purification and molecular properties of reduced nicotinamide adenine dinucleotide-dependent methemoglobin reductase. J Biol Chem 1972; 247:556–60.
Yubisui T, Matsukawa S, Yoneyama Y. Stopped flow studies on the nonenzymatic reduction of methemoglobin by reduced flavin mononucleotide. J Biol Chem 1980; 255:11694–7.
Curry S. Methemoglobinemia. Ann Emerg Med 1982; 11:214–21.
Grimes A. Human Red Cell Metabolism. In: Blackwell Scientific Publications, Oxford: 1980.
Nagababu E, Rifkind JM. Reaction of hydrogen peroxide with ferrylhemoglobin: superoxide production and heme degradation. Biochemistry 2000; 39:12503–11.
Bulbarelli A, Valentini A, DeSilvestris M et al. An erythroid-specific transcript generates the soluble form of NADH-cytochrome b5 reductase in humans. Blood 1998; 92:310–9.
Board PG, Agar NS, Gruca M et al. Methaemoglobin and its reduction in nucleated erythrocytes from reptiles and birds. Comp Biochem Physiol B 1977; 57:265–7.
Sullivan SG, Stern A. Glucose metabolism of oxidatively stressed human red blood cells incubated in plasma or medium containing physiologic concentrations of lactate, pyruvate and ascorbate. Biochem Pharmacol 1984; 33:1417–21.
Zerez CR, Lachant NA, Tanaka KR. Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content. Blood 1990; 76:1008–14.
Desagher S, Glowinski J, Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci 1997; 17:9060–7.
Lee YJ, Kang IJ, Bunger R et al. Enhanced survival effect of pyruvate correlates MAPK and NF-kappaB activation in hydrogen peroxide-treated human endothelial cells. J Appl Physiol 2004; 96:793–801; discussion 792.
Cerdan S, Rodrigues TB, Sierra A, Benito M et al. The redox switch/redox coupling hypothesis. Neurochem Int 2006; 48:523–30.
Murphy JR. Erythrocyte metabolism. II. Glucose metabolism and pathways. J Lab Clin Med 1960; 55:286–302.
Ellsworth ML, Forrester T, Ellis CG et al. The erythrocyte as a regulator of vascular tone. Am J Physiol 1995; 269:H2155–61.
Tsuneshige A, Imai K, Tyuma I. The binding of hemoglobin to red cell membrane lowers its oxygen affinity. J Biochem (Tokyo) 1987; 101:695–704.
Campanella ME, Chu H, Low PS. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci U S A 2005; 102:2402–7.
Dash RK, Bassingthwaighte JB. Blood HbO2 and HbCO2 dissociation curves at varied O2, CO2, pH, 2,3-DPG and temperature levels. Ann Biomed Eng 2004; 32:1676–93.
Suganuma K, Tsukada K, Kashiba M et al. Erythrocytes with T-state-stabilized hemoglobin as a therapeutic tool for postischemic liver dysfunction. Antioxid Redox Signal 2006; 8:1847–55.
Tsai AG, Johnson PC, Intaglietta M. Oxygen gradients in the microcirculation. Physiol Rev 2003; 83:933–63.
Soga T, Baran R, Suematsu M et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 2006; 281:16768–76.
Kuchel PW. Current status and challenges in connecting models of erythrocyte metabolism to experimental reality. Prog Biophys Mol Biol 2004; 85:325–42.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Landes Bioscience and Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kinoshita, A. (2013). Simulation of Human Erythrocyte Metabolism. In: E-Cell System. Molecular Biology Intelligence Unit. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6157-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6157-9_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6156-2
Online ISBN: 978-1-4614-6157-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)